Press Releases
Jul. 28, 2025
WHO cautions against increase of chikungunya illness
Indeterminate
MENAFN
Owner: Sawsan Dababneh
Jul. 16, 2025
National Personal Chef Day Spotlights a $16.88B Industry Transforming Luxury Dining at Home
Neutral
EIN Presswire
Jul. 22, 2025
EU Balance of Payments and International Investment Position statistical sources and methods - B.o.p. and i.i.p. e-book
Gov't Institution
ECB - European Central Bank
Owner: European Union
May. 26, 2025
NY Rum Fest & Conference takes place in Brooklyn on June 7th
Neutral
EIN Presswire
May. 8, 2025
EDITORIAL: “But who will pick our olives?” – Demographic decline and refugee inclusion
Gov't Institution
European Council on Refugees and Exiles (ECRE)
Owner: ECRE (Non-profit)
Sep. 18, 2025
Statement on the Cabinet meeting of Wednesday, 17 September 2025
Gov't Institution
South African Government
Owner: South African Government
Aug. 12, 2025
Valneva Reports Half Year 2025 Financial Results and Provides Corporate Updates
Indeterminate
GlobeNewswire, Inc.
Aug. 25, 2025
Valneva Announces FDA’s Decision to Suspend License of Chikungunya Vaccine IXCHIQ® in the U.S.
Indeterminate
GlobeNewswire, Inc.
Jul. 14, 2025
Native American Photography Book 'Dancing for Our Tribe' by Sharon Hoogstraten
Neutral
EIN Presswire
Jul. 9, 2025
Brunch Is the New NYC Ritual: Here's Where to Find the Most Delicious One This Weekend
Neutral
EIN Presswire
May. 23, 2025
Combined General Meeting of June 13, 2025
Indeterminate
GlobeNewswire, Inc.
May. 15, 2025
Combined General Meeting of June 11, 2025
Indeterminate
GlobeNewswire, Inc.
May. 12, 2025
Valneva Provides Update on Recommended Use of IXCHIQ® by Elderly Individuals in the United States
Indeterminate
GlobeNewswire, Inc.
Apr. 15, 2025
Nüspace Celebrates 20 Years: From a Taxi Garage to a Montreal Design Destination
Indeterminate
GlobeNewswire, Inc.
May. 7, 2025
Valneva Provides Update Following European Medicines Agency Announcement on Use of IXCHIQ® in Elderly
Indeterminate
GlobeNewswire, Inc.
Apr. 18, 2025
Valneva Provides Update on ACIP Recommendation for its Chikungunya Vaccine IXCHIQ® Among U.S. Travelers
Indeterminate
GlobeNewswire, Inc.